![Mark Pykett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Pykett
Directeur/Membre du Conseil chez
PHARMING GROUP N.V.
Fortune : 290 318 $ au 31/05/2026
Profil
Mark Jerome Pykett was the founder of Cytomatrix, established in 1996, where the title held was President & Chief Executive Officer from 1996 to 2003.
Current jobs include Vice Chairman at Pharming Group NV starting in 2025, Chairman at Inflectis Bioscience SAS since 2021, Chairman at MyoPax GmbH, and Director at Exubrion Therapeutics, Inc. Former jobs include Chief Executive Officer & Director at Navidea Biopharmaceuticals, Inc. in 2014, President, Chief Executive Officer & Director at Agilis Biotherapeutics LLC from 2014 to 2018, President & Chief Executive Officer at Myrtelle LLC, Director at Mast Therapeutics, Inc. in 2004, Director at Health Builders International, Inc., Director at Oramax LLC from 2000 to 2006, President & Chief Operating Officer at Alseres Pharmaceuticals, Inc. from 2004 to 2010, President at CyGenics Ltd. in 2004, and President at Cordlife Group Ltd. from 2003 to 2005, and Chief Scientific Officer at PTC Therapeutics, Inc. from 2018 to 2021.
Education includes a doctorate from the University of Pennsylvania, an undergraduate degree from Amherst College, an MBA from Northeastern University, and a doctorate from the University of Pennsylvania School of Veterinary Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PHARMING GROUP NV 0,03 % | 28/05/2026 | 216 052 ( 0,03 % ) | 290 318 $ | 31/05/2026 |
Postes actifs de Mark Pykett
| Sociétés | Poste | Début |
|---|---|---|
| PHARMING GROUP N.V. | Directeur/Membre du Conseil | 11/12/2020 |
Exubrion Therapeutics , Inc.
 Exubrion Therapeutics , Inc. Medical SpecialtiesHealth Technology Develops electron therapeutic veterinary devices | Directeur/Membre du Conseil | - |
Inflectis Bioscience SAS
 Inflectis Bioscience SAS BiotechnologyHealth Technology Develops therapeutics for the treatment of protein misfolding diseases | Président | 04/10/2021 |
MyoPax GmbH
 MyoPax GmbH Pharmaceuticals: MajorHealth Technology Develops regenerative therapies for muscle diseases | Président | - |
Anciens postes connus de Mark Pykett
| Sociétés | Poste | Fin |
|---|---|---|
| PTC THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2021 |
Agilis Biotherapeutics LLC
 Agilis Biotherapeutics LLC Pharmaceuticals: MajorHealth Technology Develops DNA therapeutics for patients with rare diseases of central nervous systems | Directeur Général | 01/01/2018 |
| NAVIDEA BIOPHARMACEUTICALS, INC. | Directeur Général | 30/05/2014 |
| ALSERES PHARMACEUTICALS, INC. | President | 04/01/2010 |
Oramax LLC | Directeur/Membre du Conseil | 01/01/2006 |
Formation de Mark Pykett
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
33
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Navidea Biopharmaceuticals, Inc.
 Navidea Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and commercializes precision diagnostics and radiopharmaceutical agents | Health Technology |
Alseres Pharmaceuticals, Inc.
 Alseres Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and diagnostic products | Health Technology |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Health Technology |
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
CyGenics Ltd.
 CyGenics Ltd. Miscellaneous Commercial ServicesCommercial Services Operates a biotechnology company active in research | Commercial Services |
Agilis Biotherapeutics LLC
Agilis Biotherapeutics LLC Pharmaceuticals: MajorHealth Technology Develops DNA therapeutics for patients with rare diseases of central nervous systems | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Health Builders International, Inc.
 Health Builders International, Inc. Financial ConglomeratesFinance Development stage company | Finance |
Cordlife Group Ltd.
 Cordlife Group Ltd. Medical/Nursing ServicesHealth Services Provides cord blood banking services | Health Services |
Pharming Group NV
 Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
Cytomatrix
 Cytomatrix Miscellaneous Commercial ServicesCommercial Services Researches, develops, and commercialize novel cell growth systems for hematopoietic (blood) stem cells | Commercial Services |
Amherst College
 Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oramax LLC | |
University of Pennsylvania School of Veterinary Medicine
 University of Pennsylvania School of Veterinary Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inflectis Bioscience SAS
Inflectis Bioscience SAS BiotechnologyHealth Technology Develops therapeutics for the treatment of protein misfolding diseases | Health Technology |
Myrtelle LLC
 Myrtelle LLC Miscellaneous Commercial ServicesCommercial Services Develops treatment for neurological diseases | Commercial Services |
Exubrion Therapeutics , Inc.
Exubrion Therapeutics , Inc. Medical SpecialtiesHealth Technology Develops electron therapeutic veterinary devices | Health Technology |
MyoPax GmbH
MyoPax GmbH Pharmaceuticals: MajorHealth Technology Develops regenerative therapies for muscle diseases | Health Technology |
